© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 05, 2012
Postmenopausal women with advanced estrogen receptorâ€“positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.
Sentinel lymph node surgery may provide a less-invasive alternative to axillary lymph node dissection for nodal staging in node-positive breast cancer.
November 29, 2012
The FDA has approved cabozantinib, a multi-targeted tyrosine kinase inhibitor, for the treatment of metastatic medullary thyroid cancer.
April 02, 2012
Tolvaptan, a vasopression V2 receptor antagonist used to increase low levels of sodium in the blood, could be a cost effective way of managing patients who have hyponatremia.